Bio-Rad Laboratories | BIO - Операционный доход





Операционный доход Изменить Дата
Abbott USD 1.85B 399M 2026-03
Agilent USD 353M 90M 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Bio Techne USD 54.46M 6.8M 2025-12
Bio-Rad Laboratories USD 53.9M 10M 2025-12
Bruker USD 76.3M 7.6M 2025-12
Charles River Laboratories USD 75.82M 57.98M 2025-12
Danaher USD 1.34B 158M 2026-03
General Electric Aerospace USD 2.32B 549M 2026-03
Illumina USD 239M 17M 2026-03
IQVIA Holdings USD 565M 2.11B 2026-03
Laboratory Of America USD 410.1M 28.1M 2026-03
Merck USD -1.88B 8.12B 2026-03
Mettler Toledo International USD 351.93M 57.73M 2025-12
Myriad Genetics USD -3M 20.3M 2025-12
OraSure Technologies USD -13.59M 2.13M 2025-12
Pacific Biosciences Of California USD -53.19M 35.08M 2025-12
Quest Diagnostics USD 399M 13M 2026-03
Repligen USD 19.98M 13K 2026-03
Revvity USD 82.77M 63.06M 2026-03
Roche Holding CHF 9.56B 3.8B 2025-12
Siemens EUR 2.57B 3M 2025-12
Standard Biotools USD -21.92M 1.55M 2025-12
Thermo Fisher Scientific USD 1.91B 389M 2026-03
Tosoh JPY 25.15B 3.51B 2025-12
Waters USD 148M 122.52M 2026-03